Skip to content
2000
Volume 17, Issue 8
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

In recent years many different nanotechnology platforms have been developed for both diagnostics and cancer therapy. Researchers have been attracted to use lipid-based nanoparticles with particle size approximately 100 nm as a new pharmaceutical delivery system or pharmaceutical formulation that can be assembled from different types of lipid or other chemical components in order to overcome biological barriers. This mini-review highlights the recently published studies in the development of lipid-based nanoparticles as appropriate vehicles in cancer diagnosis and therapy with focus on their chemical structure, formulation recipes, stability, drug encapsulation, and other factors related to their formulation.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/1389201017666160415155457
2016-07-01
2025-09-25
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/1389201017666160415155457
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test